^
1m
TGFβ signalling pathway impacts brain metastases profiles in locally advanced colorectal cancer. (PubMed, Clin Exp Metastasis)
Our results suggest the TGFβ pathway as a crucial player in the development of brain metastases in primary CRC. In some types of colorectal cancer, downregulation of the TGFβ pathway might hinder primary colorectal cancer to metastasize to the nervous system. While the paradoxical functioning of the TGFβ pathway is still not fully understood, these shed light on yet another clinical implication of this complex pathway.
Journal • Metastases
|
TGFB1 (Transforming Growth Factor Beta 1)
|
nCounter® PanCancer Progression Panel
7ms
Head and Neck Squamous Cell Carcinoma Biopsies Maintained Ex Vivo on a Perfusion Device Show Gene Changes with Time and Clinically Relevant Doses of Irradiation. (PubMed, Cancers (Basel))
Although HNSCC tissue maintained ex vivo shows a decrease in a large proportion of altered genes, 25% and 53% (48 and 96 h) do show increased expression, suggesting that the tissue remains functional. Irradiation of tumour tissue-on-chip needs to be conducted for longer time periods for specific gene changes to be observed, but we have shown, for the first time, the feasibility of using this perfusion platform for studying the genomic response of HNSCC tissue biopsies.
Journal • Preclinical • Biopsy
|
nCounter® PanCancer Progression Panel
almost2years
Comparison of Gene Expression Profiles of Signet Ring Cell Carcinoma and Poorly Cohesive Carcinoma in Early Gastric Cancer. (PubMed, Clin Med Insights Oncol)
However, Group 3 showed numerous differences in gene expression including Roundabout4 (Robo4) compared to the other groups, especially Group 1. Our data suggest that gene expression patterns were different between SRC and PC and expression of ROBO4 may play an important role in the prognosis of SRC and PC type of EGC.
Journal • Gene Expression Profile
|
KIT expression
|
nCounter® PanCancer Progression Panel
over2years
Differentially expressed mRNA/proteins can distinguish viable germ cell tumors and teratomas from necrosis in retroperitoneal lymph node resections after chemotherapy (pcRPLND). (ASCO-GU 2022)
With AGR2 and KRT19, we have identified two proteins with their corresponding genes that are significantly and differentially expressed in the pcRPLND specimen in the clinically relevant groups T vs. N. Both were successfully validated by immunohistochemistry.
AGR2 (Anterior gradient 2) • KRT19 (Keratin 19)
|
nCounter® PanCancer Progression Panel
over2years
Differentially expressed mRNA/proteins can distinguish viable germ cell tumors and teratomas from necrosis in retroperitoneal lymph node resections after chemotherapy (pcRPLND). (ASCO-GU 2022)
With AGR2 and KRT19, we have identified two proteins with their corresponding genes that are significantly and differentially expressed in the pcRPLND specimen in the clinically relevant groups T vs. N. Both were successfully validated by immunohistochemistry.
AGR2 (Anterior gradient 2) • KRT19 (Keratin 19)
|
nCounter® PanCancer Progression Panel
over2years
Low Tumor-to-Stroma Ratio Reflects Protective Role of Stroma against Prostate Cancer Progression. (PubMed, J Pers Med)
Taken together, this study shows that high stroma content can play a protective role in PCa. Automatic EpCAM-based quantification of TSR might improve prognostication in personalized medicine for PCa.
Journal
|
EPCAM (Epithelial cell adhesion molecule)
|
nCounter® PanCancer Progression Panel
over3years
Genomic GLO1 deletion modulates TXNIP expression, glucose metabolism, and redox homeostasis while accelerating human A375 malignant melanoma tumor growth. (PubMed, Redox Biol)
"While confirming our earlier finding that GLO1 deletion limits invasion and metastasis with modulation of EMT-related genes (e.g. TGFBI, MMP9, ANGPTL4, TLR4, SERPINF1), we observed that GLO1_KO melanoma cells displayed a shortened population doubling time, cell cycle alteration with increased M-phase population, and enhanced anchorage-independent growth, a phenotype supported by expression analysis (CXCL8, CD24, IL1A, CDKN1A). Concordantly, an accelerated growth rate of GLO1_KO tumors, accompanied by TXNIP overexpression and metabolic reprogramming, was observable in a SCID mouse melanoma xenograft model, demonstrating that A375 melanoma tumor growth and metastasis can be dysregulated in opposing ways as a consequence of GLO1 elimination."
Journal
|
PD-L1 (Programmed death ligand 1) • LDHA (Lactate dehydrogenase A) • CXCL8 (Chemokine (C-X-C motif) ligand 8) • CD24 (CD24 Molecule) • TLR4 (Toll Like Receptor 4) • IL1A (Interleukin 1, alpha) • MMP9 (Matrix metallopeptidase 9) • CDKN1A (Cyclin-dependent kinase inhibitor 1A) • TGFBI (Transforming Growth Factor Beta Induced)
|
CXCL8 expression
|
nCounter® PanCancer Progression Panel
over3years
Spatial profiling of gastric cancer patient-matched primary and locoregional metastases reveals principles of tumour dissemination. (PubMed, Gut)
"In GC, regional lymph node metastases are likely to originate from deeper subregions of the primary tumour. Future clinical trials of novel targeted therapies must consider assessment of deeper subregions of the primary tumour and/or metastases as several therapeutically relevant genes are only mutated, overexpressed or amplified in these regions."
Journal • Clinical
|
PIK3CD (Phosphatidylinositol-4 5-Bisphosphate 3-Kinase Catalytic Subunit Delta) • IGF1 (Insulin-like growth factor 1) • TGFB1 (Transforming Growth Factor Beta 1)
|
nCounter® PanCancer Progression Panel